NeoCore Technology Co (4131.TWO) Akcie Kurz

NeoCore Technology Co Ltd, listed on the Taiwan Stock Exchange with ticker 4131.TWO, operates in the Health Care sector within the Biotechnology industry. Headquartered in Tainan, Taiwan, the company went public on March 12, 2003. It develops and sells biochips, DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, testing reagents, nucleic acid sequencing detection systems, biotechnology control hardware and software, biomedical materials, and nutritional supplements. Products are sold domestically and exported to Asia and Europe.